Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnetic Resonance Assessment of Victoza Efficacy in Cardiovascular Dysfunction in Type 2 Diabetes Mellitus
2012-001623-12Phase 4Terminated
- Sponsor
- Leiden University Medical Center
- Start
- Jan 2013
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM) and cardiovascular dysfunction, sponsored by Leiden University Medical Center. Primary endpoint: Systolic cardiac function parameters. Started Jan 2013; status: terminated.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)cardiovascular dysfunction
Beyond the preview
Go deeper on 2012-001623-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001623-12.